TY - JOUR
T1 - New reference limits for cardiac troponin T and N-terminal b-type natriuretic propeptide in elders
AU - Heikkilä, Elisa
AU - Katajamäki, Taina
AU - Salminen, Marika
AU - Irjala, Kerttu
AU - Viljanen, Anna
AU - Koivula, Marja-Kaisa
AU - Pulkki, Kari
AU - Isoaho, Raimo
AU - Kivelä, Sirkka Liisa
AU - Viitanen, Matti
AU - Löppönen, Minna
AU - Vahlberg, Tero
AU - Viikari, Laura
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2024/3/15
Y1 - 2024/3/15
N2 - Background and aims: Our aim was to define reference limits for cardiac troponin T (cTnT) and N-terminal pro B-type natriuretic peptide (proBNP) that would better reflect their concentrations in older people. In addition, the incidence of acute myocardial infarctions (AMIs) was studied using these reference limits in an older population with and without previous heart diseases. Materials and methods: A population-based study with a ten-year follow-up. The reference population was formed by 763 individuals aged over 64 years, with no diagnoses of heart or kidney diseases. Results: There was a significant increase in cTnT and proBNP concentrations with age. The 99 % reference limits for cTnT were 25 ng/L, 28 ng/l, 38 ng/l, and 71 ng/l for men in five-year-intervals starting from 64 to 69 years to 80 years and older, and 18 ng/L, 22 ng/l, 26 ng/l, and 52 ng/L for women, respectively. The 97.5 % reference limits for proBNP were 272 ng/L, 287 ng/l, 373 ng/l and 686 ng/L for men, and 341 ng/L, 377 ng/l, 471 ng/l, and 794 ng/L for women, respectively. Elevated proBNP was statistically significantly associated with future AMIs in subjects with and without a previous heart disease. Conclusions: Age-specific reference limits for cTnT and proBNP are needed to better evaluate cardiac symptoms.
AB - Background and aims: Our aim was to define reference limits for cardiac troponin T (cTnT) and N-terminal pro B-type natriuretic peptide (proBNP) that would better reflect their concentrations in older people. In addition, the incidence of acute myocardial infarctions (AMIs) was studied using these reference limits in an older population with and without previous heart diseases. Materials and methods: A population-based study with a ten-year follow-up. The reference population was formed by 763 individuals aged over 64 years, with no diagnoses of heart or kidney diseases. Results: There was a significant increase in cTnT and proBNP concentrations with age. The 99 % reference limits for cTnT were 25 ng/L, 28 ng/l, 38 ng/l, and 71 ng/l for men in five-year-intervals starting from 64 to 69 years to 80 years and older, and 18 ng/L, 22 ng/l, 26 ng/l, and 52 ng/L for women, respectively. The 97.5 % reference limits for proBNP were 272 ng/L, 287 ng/l, 373 ng/l and 686 ng/L for men, and 341 ng/L, 377 ng/l, 471 ng/l, and 794 ng/L for women, respectively. Elevated proBNP was statistically significantly associated with future AMIs in subjects with and without a previous heart disease. Conclusions: Age-specific reference limits for cTnT and proBNP are needed to better evaluate cardiac symptoms.
KW - Cardiac biomarkers
KW - Elderly
KW - Myocardial infarction
KW - Natriuretic peptide
KW - Reference limits
KW - Troponin
KW - 3111 Biomedicine
U2 - 10.1016/j.cca.2024.117844
DO - 10.1016/j.cca.2024.117844
M3 - Article
SN - 0009-8981
VL - 556
JO - Clinica Chimica Acta
JF - Clinica Chimica Acta
M1 - 117844
ER -